NCT06200116 Evaluation of a Novel Auto Segmentation Algorithm for Normal Structure Delineation in Radiation Treatment Planning
| NCT ID | NCT06200116 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Malignant Solid Neoplasm |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-12-02 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2024-12-02 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study measures the utility of a novel artificial intelligence (AI) algorithm for performing auto-segmentation of computed tomography (CT) scans for radiation therapy planning.
Eligibility Criteria
Inclusion Criteria: * Employment at Mayo Clinic Arizona, Florida, or Rochester (which includes Regional Practice sites located at Mayo Clinic Health System locations) as train clinical staff that participate in normal tissue segmentation Exclusion Criteria: * Inability to complete study surveys
Contact & Investigator
Doug J. Moseley, PhD
PRINCIPAL INVESTIGATOR
Mayo Clinic in Rochester
Frequently Asked Questions
Who can join the NCT06200116 clinical trial?
This trial is open to participants of all sexes, studying Malignant Solid Neoplasm. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06200116 currently recruiting?
Yes, NCT06200116 is actively recruiting participants. Contact the research team at mayocliniccancerstudies@mayo.edu for enrollment information.
Where is the NCT06200116 trial being conducted?
This trial is being conducted at Scottsdale, United States, Jacksonville, United States, Albert Lea, United States, Mankato, United States and 3 additional locations.
Who is sponsoring the NCT06200116 clinical trial?
NCT06200116 is sponsored by Mayo Clinic. The principal investigator is Doug J. Moseley, PhD at Mayo Clinic in Rochester. The trial plans to enroll 200 participants.